Andros Pharmaceuticals Co (ROCO:6917) Change In Receivables : NT$-0.12 Mil (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Andros Pharmaceuticals Co Change In Receivables?

Andros Pharmaceuticals Co's change in receivables for the quarter that ended in Jun. 2024 was NT$-0.11 Mil. It means Andros Pharmaceuticals Co's Accounts Receivable increased by NT$0.11 Mil from Dec. 2023 to Jun. 2024 .

Andros Pharmaceuticals Co's change in receivables for the fiscal year that ended in Dec. 2023 was NT$6.37 Mil. It means Andros Pharmaceuticals Co's Accounts Receivable declined by NT$6.37 Mil from Dec. 2022 to Dec. 2023 .

Andros Pharmaceuticals Co's Accounts Receivable for the quarter that ended in Jun. 2024 was NT$0.06 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Andros Pharmaceuticals Co's Days Sales Outstanding for the six months ended in Jun. 2024 was 135.64.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Andros Pharmaceuticals Co's liquidation value for the six months ended in Jun. 2024 was NT$356.34 Mil.

Andros Pharmaceuticals Co Change In Receivables Historical Data

The historical data trend for Andros Pharmaceuticals Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Andros Pharmaceuticals Co Change In Receivables Chart

Andros Pharmaceuticals Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

0.02

-6.19

1.72

-1.99

6.37

Andros Pharmaceuticals Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Change In Receivables	Get a 7-Day Free Trial				-1.14	-0.85	6.39	-0.02	-0.11

Andros Pharmaceuticals Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.12 Mil.

Andros Pharmaceuticals Co (ROCO:6917) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Andros Pharmaceuticals Co's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.055	/	0.074	*	91
=	135.64

2. In Ben Graham's calculation of liquidation value, Andros Pharmaceuticals Co's accounts receivable are only considered to be worth 75% of book value:

Andros Pharmaceuticals Co's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	397.922	-	42.123	+	0.75 * 0.055	+	0.5 * 1.008
=	356.34

Andros Pharmaceuticals Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Andros Pharmaceuticals Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Andros Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 22, Sec. 2, Shengyi Road, 6th Floor, Building D, Biotech Building, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei City, TWN, 30261

Website

http://www.androspharma.com

Andros Pharmaceuticals Co Ltd is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The firm focuses on the development of topical new dosage forms and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy. Its product line comprises New Dosage Forms (Topical), Super Generics (Topical), High-End Cosmetic Ingredients (Topical), and Gene Delivery Systems (Injectable).

Andros Pharmaceuticals Co Headlines

No Headlines